Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy
Conditions: Metastatic Breast Cancer Interventions: Combination Product: Meritup oral solution Sponsors: Chung Shan Medical University; Phytofound Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid Leukemia
EDINBURGH, Scotland, Nov. 27, 2023. TC BioPharm (Holdings) PLC ( " TC BioPharm " or the " Company " ) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, announced today that the FDA... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 28, 2023 Category: Pharmaceuticals Source Type: clinical trials
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Conditions: Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma Interventions: Biological: CD19-targeted Chimeric Antigen Receptor(CAR) T Cells Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)
Conditions: Solid Tumor; Gynecological Tumors Interventions: Biological: GT316 Sponsors: Grit Biotechnology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus (SLE) Interventions: Drug: SG301 SC Injection Sponsors: Hangzhou Sumgen Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
GT201 Injection For The Treatment Of Advanced Solid Tumors
Conditions: Solid Tumor, Adult Interventions: Drug: GT201 Sponsors: Grit Biotechnology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Conditions: Liver Carcinoma; Hepatic Cell Carcinoma Interventions: Biological: CAR-GPC3 T cells Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Relmacabtagene Autoleucel in Hematologic Malignancies
Conditions: Lymphoma, B-Cell; Large B-cell Lymphoma; Follicular Lymphoma Interventions: Biological: Relmacabtagene Autoleucel Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Relmacabtagene Autoleucel in Patients With LBCL
Conditions: Large B-cell Lymphoma Interventions: Biological: Relmacabtagene Autoleucel Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
Conditions: T-lymphoblastic Lymphoma; T-ALL Interventions: Biological: CAR-T Sponsors: Hebei Senlang Biotechnology Inc., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients
YANTAI, China, Nov. 15, 2023. RemeGen Co., Ltd. ( " RemeGen " or " the Company " ), a commercial-stage biotechnology company, is invited to present telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 15, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Clinical Trial of Rabies Vaccine （Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years
Conditions: Rabies Interventions: Biological: Rabies Vaccine （Human Diploid Cell）for Human Use,Freeze-dried Sponsors: Ab&b Biotechnology Co., Ltd.JS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Other: APRIL-BAFF-Bicephali CAR-T cells Sponsors: Xuzhou Medical University; Yake Biotechnology Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
Conditions: Locally Advanced/Metastatic Solid Tumors Interventions: Drug: FL115 Sponsors: Suzhou Forlong Biotechnology Co.,Ltd, Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Conditions: Sarcoma Interventions: Drug: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell) Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
